PTC Therapeutics, Inc. Payments to Acquire Marketable Securities
PTC Therapeutics, Inc. (PTCT) reported Payments to Acquire Marketable Securities of $32.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-07-30
- PTC Therapeutics, Inc. payments to acquire marketable securities for the quarter ending 2026-06-30 was $9.02M, a 23.70% decline year-over-year.
- PTC Therapeutics, Inc. payments to acquire marketable securities for the quarter ending 2026-03-31 was $23.96M, a 359.92% increase year-over-year.
- PTC Therapeutics, Inc. payments to acquire marketable securities for the quarter ending 2025-12-31 was $7.09M, a 27.37% decline year-over-year.
- PTC Therapeutics, Inc. payments to acquire marketable securities for the quarter ending 2025-09-30 was $29.51M, a 8.38% decline year-over-year.
- PTC Therapeutics, Inc. payments to acquire marketable securities for fiscal 2025 was $53.63M, a 9.68% decline from fiscal 2024.
- PTC Therapeutics, Inc. payments to acquire marketable securities for fiscal 2024 was $59.38M, a 54.64% increase from fiscal 2023.
- PTC Therapeutics, Inc. payments to acquire marketable securities for fiscal 2023 was $38.40M, a 68.51% increase from fiscal 2022.
- PTC Therapeutics, Inc. payments to acquire marketable securities for fiscal 2022 was $22.79M, a 89.15% decline from fiscal 2021.
| Period end | Payments to Acquire Marketable Securities 1 month | Payments to Acquire Marketable Securities 1 month as first filed | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 6 month as first filed | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 9 month as first filed | Payments to Acquire Marketable Securities 12 month | Payments to Acquire Marketable Securities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $9.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $32.98M 10-Q · filed 2026-07-30 | $40.07M derived: sum of 3 quarters · filed 2026-07-30 | $69.58M derived: sum of 4 quarters · filed 2026-07-30 | |||||
| 2026-03-31 | $23.96M 10-Q · filed 2026-05-07 | $31.05M derived: sum of 2 quarters · filed 2026-05-07 | $60.56M derived: sum of 3 quarters · filed 2026-05-07 | $72.38M derived: sum of 4 quarters · filed 2026-07-30 | |||||
| 2025-12-31 | $7.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $36.60M derived: sum of 2 quarters · filed 2026-02-19 | $48.42M derived: sum of 3 quarters · filed 2026-07-30 | $53.63M 10-K · filed 2026-02-19 | |||||
| 2025-09-30 | $29.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $41.33M derived: sum of 2 quarters · filed 2026-07-30 | $46.54M 10-Q · filed 2025-11-04 | $56.30M derived: sum of 4 quarters · filed 2026-07-30 | |||||
| 2025-06-30 | $11.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $17.03M 10-Q · filed 2026-07-30 | $26.79M derived: sum of 3 quarters · filed 2026-07-30 | $59.00M derived: sum of 4 quarters · filed 2026-07-30 | |||||
| 2025-03-31 | $5.21M 10-Q · filed 2026-05-07 | $14.97M derived: sum of 2 quarters · filed 2026-05-07 | $47.18M derived: sum of 3 quarters · filed 2026-05-07 | $55.52M derived: sum of 4 quarters · filed 2026-05-07 | |||||
| 2024-12-31 | $9.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $41.97M derived: sum of 2 quarters · filed 2026-02-19 | $50.31M derived: sum of 3 quarters · filed 2026-02-19 | $59.38M 10-K · filed 2026-02-19 | |||||
| 2024-09-30 | $32.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $40.55M derived: sum of 2 quarters · filed 2025-11-04 | $49.61M 10-Q · filed 2025-11-04 | $61.63M derived: sum of 4 quarters · filed 2026-02-19 | |||||
| 2024-06-30 | $8.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $17.41M 10-Q · filed 2025-08-07 | $29.43M derived: sum of 3 quarters · filed 2026-02-19 | $37.65M derived: sum of 4 quarters · filed 2026-02-19 | |||||
| 2024-03-31 | $9.06M 10-Q · filed 2025-05-06 | $21.09M derived: sum of 2 quarters · filed 2026-02-19 | $29.30M derived: sum of 3 quarters · filed 2026-02-19 | ||||||
| 2023-12-31 | $12.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $20.24M derived: sum of 2 quarters · filed 2026-02-19 | $38.40M 10-K · filed 2026-02-19 | ||||||
| 2023-09-30 | $8.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $26.38M 10-Q · filed 2024-11-07 | |||||||
| 2023-06-30 | $18.16M 10-Q · filed 2024-08-08 | ||||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $22.79M 10-K · filed 2025-02-27 | |||||||
| 2022-09-30 | $22.79M 10-Q · filed 2023-10-26 | ||||||||
| 2021-12-31 | $4.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $10.02M derived: sum of 2 quarters · filed 2024-02-29 | $10.02M derived: sum of 3 quarters · filed 2024-02-29 | $210.02M 10-K · filed 2024-02-29 | |||||
| 2021-09-30 | $5.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $5.38M derived: sum of 2 quarters · filed 2022-10-27 | $205.38M 10-Q · filed 2022-10-27 | $638.10M derived: sum of 4 quarters · filed 2022-10-27 | |||||
| 2021-08-31 | $10.00M 10-Q · filed 2022-08-04 | $5.40M 10-Q · filed 2021-10-28 | |||||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $200.00M 10-Q · filed 2022-08-04 | $632.72M derived: sum of 3 quarters · filed 2022-08-04 | $1.27B derived: sum of 4 quarters · filed 2022-08-04 | |||||
| 2021-03-31 | $200.00M 10-Q · filed 2022-05-03 | $632.72M derived: sum of 2 quarters · filed 2022-05-03 | $1.27B derived: sum of 3 quarters · filed 2022-05-03 | $1.34B derived: sum of 4 quarters · filed 2022-05-03 | |||||
| 2021-02-28 | $200.00M 10-Q · filed 2021-10-28 | ||||||||
| 2020-12-31 | $432.72M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.07B derived: sum of 2 quarters · filed 2021-02-25 | $1.14B derived: sum of 3 quarters · filed 2021-02-25 | $1.44B 10-K · filed 2021-02-25 | |||||
| 2020-09-30 | $639.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $708.13M derived: sum of 2 quarters · filed 2020-10-29 | $1.01B 10-Q · filed 2020-10-29 | $1.26B derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2020-06-30 | $68.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $367.10M 10-Q · filed 2020-08-05 | $621.78M derived: sum of 3 quarters · filed 2021-02-25 | $634.91M derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2020-03-31 | $298.81M 10-Q · filed 2020-04-30 | $553.50M derived: sum of 2 quarters · filed 2021-02-25 | $566.62M derived: sum of 3 quarters · filed 2021-02-25 | $627.16M derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2019-12-31 | $254.68M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $267.81M derived: sum of 2 quarters · filed 2021-02-25 | $328.35M derived: sum of 3 quarters · filed 2021-02-25 | $494.07M 10-K · filed 2021-02-25 | |||||
| 2019-09-30 | $13.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $73.66M derived: sum of 2 quarters · filed 2020-10-29 | $239.39M 10-Q · filed 2020-10-29 | $279.34M derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2019-06-30 | $60.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $226.26M 10-Q · filed 2020-08-05 | $266.22M derived: sum of 3 quarters · filed 2021-02-25 | $266.22M derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2019-03-31 | $165.72M 10-Q · filed 2020-04-30 | $205.68M derived: sum of 2 quarters · filed 2021-02-25 | $205.68M derived: sum of 3 quarters · filed 2021-02-25 | $211.65M derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2018-12-31 | $39.96M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $39.96M derived: sum of 2 quarters · filed 2021-02-25 | $45.93M derived: sum of 3 quarters · filed 2021-02-25 | $68.61M 10-K · filed 2021-02-25 | |||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $5.97M derived: sum of 2 quarters · filed 2019-10-30 | $28.66M 10-Q · filed 2019-10-30 | $90.56M derived: sum of 4 quarters · filed 2020-03-02 | |||||
| 2018-06-30 | $5.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $28.66M 10-Q · filed 2019-08-06 | $90.56M derived: sum of 3 quarters · filed 2020-03-02 | $90.56M derived: sum of 4 quarters · filed 2020-03-02 | |||||
| 2018-03-31 | $22.68M 10-Q · filed 2019-05-02 | $84.58M derived: sum of 2 quarters · filed 2020-03-02 | $84.58M derived: sum of 3 quarters · filed 2020-03-02 | $84.58M derived: sum of 4 quarters · filed 2020-03-02 | |||||
| 2017-12-31 | $61.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $61.90M derived: sum of 2 quarters · filed 2020-03-02 | $61.90M derived: sum of 3 quarters · filed 2020-03-02 | $81.37M 10-K · filed 2020-03-02 | |||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $0.00 derived: sum of 2 quarters · filed 2018-11-05 | $19.47M 10-Q · filed 2018-11-05 | $31.15M derived: sum of 4 quarters · filed 2019-03-01 | |||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $19.47M 10-Q · filed 2018-08-07 | $31.15M derived: sum of 3 quarters · filed 2019-03-01 | $58.59M derived: sum of 4 quarters · filed 2019-03-01 | |||||
| 2017-03-31 | $19.47M 10-Q · filed 2018-05-09 | $31.15M derived: sum of 2 quarters · filed 2019-03-01 | $58.59M derived: sum of 3 quarters · filed 2019-03-01 | $85.43M derived: sum of 4 quarters · filed 2019-03-01 | |||||
| 2016-12-31 | $11.69M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $39.12M derived: sum of 2 quarters · filed 2019-03-01 | $65.96M derived: sum of 3 quarters · filed 2019-03-01 | $85.38M 10-K · filed 2019-03-01 | |||||
| 2016-09-30 | $27.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $54.28M derived: sum of 2 quarters · filed 2017-11-02 | $73.69M 10-Q · filed 2017-11-02 | $163.16M derived: sum of 4 quarters · filed 2018-03-06 | |||||
| 2016-06-30 | $26.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $46.26M 10-Q · filed 2017-08-09 | $135.72M derived: sum of 3 quarters · filed 2018-03-06 | $225.03M derived: sum of 4 quarters · filed 2018-03-06 | |||||
| 2016-03-31 | $19.41M 10-Q · filed 2017-05-08 | $108.88M derived: sum of 2 quarters · filed 2018-03-06 | $198.19M derived: sum of 3 quarters · filed 2018-03-06 | $224.07M derived: sum of 4 quarters · filed 2018-03-06 | |||||
| 2015-12-31 | $89.46M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $178.77M derived: sum of 2 quarters · filed 2018-03-06 | $204.65M derived: sum of 3 quarters · filed 2018-03-06 | $223.76M 10-K · filed 2018-03-06 | |||||
| 2015-09-30 | $89.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $115.19M derived: sum of 2 quarters · filed 2016-11-03 | $134.30M 10-Q · filed 2016-11-03 | $249.50M derived: sum of 4 quarters · filed 2017-03-16 | |||||
| 2015-06-30 | $25.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $44.99M 10-Q · filed 2016-08-04 | $160.19M derived: sum of 3 quarters · filed 2017-03-16 | $160.19M derived: sum of 4 quarters · filed 2017-03-16 | |||||
| 2015-03-31 | $19.11M 10-Q · filed 2016-05-05 | $134.31M derived: sum of 2 quarters · filed 2017-03-16 | $134.31M derived: sum of 3 quarters · filed 2017-03-16 | $241.56M derived: sum of 4 quarters · filed 2017-03-16 | |||||
| 2014-12-31 | $115.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $115.20M derived: sum of 2 quarters · filed 2017-03-16 | $222.45M derived: sum of 3 quarters · filed 2017-03-16 | $247.80M 10-K · filed 2017-03-16 | |||||
| 2014-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $107.25M derived: sum of 2 quarters · filed 2015-11-09 | $132.60M 10-Q · filed 2015-11-09 | $148.92M derived: sum of 4 quarters · filed 2016-02-29 | |||||
| 2014-06-30 | $107.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $132.60M 10-Q · filed 2015-07-31 | $148.92M derived: sum of 3 quarters · filed 2016-02-29 | $277.04M derived: sum of 4 quarters · filed 2016-02-29 | |||||
| 2014-03-31 | $25.35M 10-Q · filed 2015-05-05 | $41.67M derived: sum of 2 quarters · filed 2016-02-29 | $169.79M derived: sum of 3 quarters · filed 2016-02-29 | ||||||
| 2013-12-31 | $16.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $144.44M derived: sum of 2 quarters · filed 2016-02-29 | $156.04M 10-K · filed 2016-02-29 | $156.04M 10-K · filed 2014-03-06 | |||||
| 2013-09-30 | $128.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $139.73M 10-Q · filed 2014-11-06 | $139.73M 10-Q · filed 2013-11-14 | ||||||
| 2013-06-30 | $11.60M 10-Q · filed 2014-08-07 | $11.60M 10-Q · filed 2013-08-13 | |||||||
| 2011-12-31 | $2.02M 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |